Search - tctmd.com

Displaying 121 - 140 of 306

Sort: Relevancy | Date

News Daily News

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Michael O'Riordan

September 27, 2023

News Daily News

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Michael O'Riordan

September 18, 2023

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

L.A. McKeown

September 01, 2023

News Conference News ESC 2023

Early SGLT2 Inhibition, Spot Urine Sodium Checks May Help in Acute HF

Todd Neale

September 01, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients

Todd Neale

July 17, 2023

News CV Team Pro

Viet Le

L.A. McKeown

July 07, 2023

News Daily News

Keto Diet for Heart Failure? What Clinicians, Patients Need to Know

Caitlin E. Cox

July 06, 2023

News Daily News

Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF

Todd Neale

July 03, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Conference News ESC Heart Failure 2023

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

L.A. McKeown

June 06, 2023

News Opinion CV Team Dispatch

June 2023 News Roundup

L.A. McKeown

June 01, 2023

News Daily News

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

Shelley Wood

May 30, 2023

News Conference News ESC Heart Failure 2023

Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues

Shelley Wood

May 25, 2023

News Conference News ESC Heart Failure 2023

More ARNI Insights Fortify Role in ‘Below Normal’ LVEF: PARAGLIDE-HF

Shelley Wood

May 22, 2023

News Conference News ESC Heart Failure 2023

CardioMEMS Beats Standard Care in First European RCT: MONITOR-HF

Shelley Wood

May 21, 2023

News Conference News EuroPCR 2023

Transcatheter MV Replacement vs Best Medical Therapy? Some Clues

Shelley Wood

May 17, 2023

Advertisement

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

Early SGLT2 Inhibition, Spot Urine Sodium Checks May Help in Acute HF

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients

Viet Le

Keto Diet for Heart Failure? What Clinicians, Patients Need to Know

Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

June 2023 News Roundup

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues

More ARNI Insights Fortify Role in ‘Below Normal’ LVEF: PARAGLIDE-HF

CardioMEMS Beats Standard Care in First European RCT: MONITOR-HF

Transcatheter MV Replacement vs Best Medical Therapy? Some Clues

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content